Mucormycosis--early diagnosis and treatment. (2004 study) Skip to main content
Retrospective Study Revue de laryngologie - otologie - rhinologie 2004

Mucormycosis--early diagnosis and treatment.

Guevara N, Roy D, Dutruc-Rosset C, Santini J, Hofman P, Castillo L, Revue de laryngologie - otologie - rhinologie, 2004

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Doctors reviewed the records of 9 patients treated for a serious fungal infection of the nose, sinuses, and surrounding tissue (rhino-orbital-cerebral mucormycosis) between 1973 and 2001 to see how it was diagnosed and treated.

What They Found

This retrospective case series of 9 patients found that early diagnosis using nasal endoscopy and frozen section testing was achieved in 5 of the 9 patients, later confirmed by full histology. Treatment included antifungal medication (amphotericin B given systemically or locally), hyperbaric oxygen, and surgical debridement (done endoscopically or through external surgery, with or without removal of eye tissue). Overall, 5 of the 9 patients survived. The study did not report statistical testing comparing outcomes between treatment approaches.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a small, retrospective case series of only 9 patients gathered over nearly three decades, with no control group or statistical comparison, so it cannot show which specific treatment contributed to survival.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Neurological
Source Pubmed
PubMed ID 15462174
Year Published 2004
Journal Revue de laryngologie - otologie - rhinologie
MeSH Terms Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brain Diseases; Debridement; Endoscopy; Female; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Mucormycosis; Nose Diseases

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology